Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-13

Clinical Trial Update: A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]

View source ↗

Summary

This Phase 3 multicenter trial evaluated the long-term safety and efficacy of aripiprazole in combination with a mood stabilizer for Bipolar I Disorder patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-03-13